Pam Mangat-Dhaliwal

Pam Mangat-Dhaliwal has a diverse work experience in the field of clinical research and analytics. Pam began their career in 2005 as a Senior Research Assistant at Simon Fraser University. In 2008, they joined Bridge Laboratories as a Data Quality Assurance Specialist, where they provided regulatory-compliant drug development services. In 2010, they joined The George Washington University Biostatistics Center as a Research Associate, specializing in data management and protocol development for national multi-site clinical trials.

Pam's career then progressed to the American Society of Clinical Oncology (ASCO), where they held various positions. From 2015 to 2016, they served as a Research Study Manager in the Research and Analysis Division. Later, from 2017 to 2018, they worked as an Associate Director at the Center for Research and Analytics. In 2019, Pam was promoted to Director, Clinical Research, at the same center, focusing on Precision Oncology. Currently, they hold the position of Division Director, Clinical Research and Analytics at ASCO's Center for Research and Analytics, a role they have held since January 2022.

In addition to their work at ASCO, Pam has also been involved with the Society for Clinical Trials since 2020, serving as a Program Committee Member. In this role, they contribute to the development of the scientific program and sessions for the organization's annual meeting.

Overall, Pam Mangat-Dhaliwal has demonstrated expertise in clinical research, data management, and protocol development throughout their career.

Pam Mangat-Dhaliwal is currently pursuing a Doctor of Philosophy (PhD) degree in Translational Research, which is expected to be completed by 2023 at The George Washington University. Prior to this, they obtained a Master's degree in Epidemiology and Biostatistics from The George Washington University from 2011 to 2014. Pam also holds a Bachelor's degree in Cellular and Molecular Biology from Simon Fraser University, obtained from 2001 to 2005.